Skip to main content
MEDICOX Co., Ltd. logo

MEDICOX Co., Ltd. — Investor Relations & Filings

Ticker · 054180 ISIN · KR7054180005 KO Manufacturing
Open in API
Filings indexed 803 across all filing types
Latest filing 2025-01-23 AGM Information
Country KR South Korea
Listing KO 054180

About MEDICOX Co., Ltd.

https://www.medicox.co.kr

MEDICOX Co., Ltd., formerly ChoongAng Ocean Co Ltd, is a company engaged in the manufacture and sale of shipbuilding materials and equipment. Its primary products are structural components for large vessels, including curved blocks, bow and stern sections, propeller bosses, and engine room parts. In addition to its core shipbuilding business, the company is diversifying into the biopharmaceutical sector, focusing on new drug development and the commercialization of pharmaceutical products.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a regulatory filing from a Korean company (Medicox) regarding the 'Resolution to Convene a General Meeting of Shareholders' (주주총회소집결의). It details the agenda for an upcoming Extraordinary General Meeting, including the appointment of directors and changes to business purposes. This type of document is a formal proxy solicitation and information statement provided to shareholders to inform them of meeting details and agenda items, which falls under the Proxy Solicitation & Information Statement category.
2025-01-23 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Extraordinary General Meeting of Shareholders' (주주총회소집공고) for the company 'Medicox' (주식회사 메디콕스). It details the meeting date, location, agenda items (such as amendments to the articles of incorporation and election of directors), and provides management reference materials (경영참고사항) including board activity reports and business overviews. This document is a standard proxy statement/notice sent to shareholders to inform them of an upcoming meeting and solicit their participation/votes. In the context of the provided categories, this aligns with 'Proxy Solicitation & Information Statement'.
2025-01-23 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from a Korean company, Medicox, specifically detailing a 'Decision on Paid-in Capital Increase' (유상증자결정). It is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange. Since it involves a change in capital structure (issuing new shares) and is a formal regulatory disclosure, it falls under the 'Share Issue/Capital Change' category.
2025-01-22 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and Korea Exchange. This type of filing is a standard regulatory requirement in South Korea for entities that acquire a significant stake (typically 5% or more) in a publicly traded company. It details the identity of the shareholder, the number of shares held, the purpose of the holding, and any recent changes in ownership. This falls under the category of 'Major Shareholding Notification'.
2025-01-20 Korean
전환사채(해외전환사채포함)발행후만기전사채취득 (제20회차)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the acquisition of convertible bonds before maturity by the issuer (Medicox). It details the specific bond series (20th series), the acquisition amount, the reason for acquisition, and the method of acquisition. This falls under capital structure changes and financing updates, specifically related to debt instruments, which is best classified as a Capital/Financing Update (CAP).
2024-12-31 Korean
주요사항보고서(자기전환사채매도결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange regarding the 'Decision to Sell Own Convertible Bonds' (자기전환사채매도결정). This involves the company's capital structure and financing activities, specifically the disposal of treasury convertible bonds. Since it relates to financing and capital structure changes rather than a general regulatory announcement or a share issue, it falls under the Capital/Financing Update category.
2024-12-31 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.